Icariin ameliorates cisplatin-induced cytotoxicity in human embryonic kidney 293 cells by suppressing ROS-mediated PI3K/Akt pathway
Open Access
- 1 January 2019
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 109, 2309-2317
Abstract
No abstract availableKeywords
Funding Information
- Program for the Young Top-notch and Innovative Talents of Jilin Agricultural University (2016JLAU0307)
- International Science & Technology Cooperation Program of China (2015DFA31290)
This publication has 39 references indexed in Scilit:
- Amelioration of cisplatin-induced mouse renal lesions by a cyclooxygenase (COX)-2 selective inhibitorEuropean Journal of Pharmacology, 2013
- Cisplatin-induced injury of the renal distal convoluted tubule is associated with hypomagnesaemia in miceNephrology Dialysis Transplantation, 2012
- Cisplatin-loaded core cross-linked micelles: comparative pharmacokinetics, antitumor activity, and toxicity in miceInternational Journal of Nanomedicine, 2012
- Herba Epimedii: Anti-Oxidative Properties and Its Medical ImplicationsMolecules, 2010
- Icariin attenuates β-amyloid-induced neurotoxicity by inhibition of tau protein hyperphosphorylation in PC12 cellsNeuropharmacology, 2010
- Icariin attenuates LPS-induced acute inflammatory responses: Involvement of PI3K/Akt and NF-κB signaling pathwayEuropean Journal of Pharmacology, 2010
- Protective effect of carnosine against cisplatin-induced nephrotoxicity in miceEnvironmental Toxicology and Pharmacology, 2008
- Cisplatin nephrotoxicity: Mechanisms and renoprotective strategiesKidney International, 2008
- Cisplatin Nephrotoxicity: A ReviewThe American Journal of the Medical Sciences, 2007
- The Bcl2 family: regulators of the cellular life-or-death switchNature Reviews Cancer, 2002